发明名称 |
On01910. Na enhances chemotherapeutic agent activity in drug-resistant tumors |
摘要 |
The invention includes compositions and methods of treatment of cancers susceptible to treatment with nucleotide analog chemotherapeutic agent, including cancers in which nucleotide analog resistant tumors have developed, including identifying a subject having cancer susceptible to treatment with a nucleotide analog chemotherapeutic agent and a mitotic disruptor/polo-like kinase (PIk) pathway inhibitor to a subject; and monitoring the subject for a reduction of stabilization of at least one sign or symptom of cancer. |
申请公布号 |
AU2008354754(A1) |
申请公布日期 |
2009.10.22 |
申请号 |
AU20080354754 |
申请日期 |
2008.04.17 |
申请人 |
THE JOHNS HOPKINS UNIVERSITY |
发明人 |
ANTONIO JIMENO;MANUEL MEDINA HIDALGO |
分类号 |
A61K31/425 |
主分类号 |
A61K31/425 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|